Children with fever treated with anti-malarial drugs

Indicator Name

% of children under age 5 with confirmed or presumptive malaria (fever or history of fever) in the last 2 weeks who received anti-malarial treatment (in areas with malaria)

Indicator ID in PRIME

IN00021497

Definition

Definition

This indicator measures the percentage of children under age 5 with confirmed or presumptive malaria (fever or history of fever) in the last 2 weeks who received anti-malarial treatment (in areas with malaria).

Numerator

Number of children under age 5 with confirmed or presumptive malaria (fever or history of fever) in the last 2 weeks who received anti-malarial treatment (in areas with malaria)

Denominator

Total number of children under age 5 with confirmed or presumptive malaria (fever or history of fever) in the last 2 weeks (in areas with malaria)

Recommended Means of Verification

Collect the following data by conducting individual interviews with (a representative sample of) mothers of children under age 5, inquiring if their children had experienced fever in the 2 weeks preceding the survey and what treatment was received:
Has [name] been ill with a fever at any time in the last 2 weeks?
At any time during the illness, did [name] take any medicine for the illness?
What medicine did [name] take? Antimalarial medicine/antibiotic medicine/other medicine?
(A complete list of questions is available via links provided)

To calculate the indicator's value, divide the number of children under age 5 with confirmed or presumptive malaria (fever) in the last 2 weeks who received anti-malarial treatment (in areas with malaria) by the total number of children under age 5 with confirmed or presumptive malaria (fever) in the last 2 weeks (in areas with malaria). Multiply the result by 100 to convert it to a percentage.

Indicator Attributes

Indicator Prioritisation

Global Indicator

Level of Indicator

Outcome

Indicator Context Type

Quantitative

Theme

Health & Nutrition

Sub Theme

Child Health

Common Approach

Saving Newborn Lives, Treating Children Close to Home (Integrated Community Case Management)

Total Reach Indicator

No

Context

Development

Measurement GuidanceĀ 

Frequency of Data Collection

Annually

Unit of Measure

Individual

Data Format

Percent

Direction of Desired Change

Increasing

Number of Decimal Points

Zero

Indicator is Rounding

No

Nature

Cumulative

Recommended Disaggregations

Gender Group TR

Tools

Has [name] had an illness with a cough at any time in the last 2 weeks?
Has [name] had fast, short, rapid breaths or difficulty breathing at any time in the last 2 weeks?
Was the fast or difficult breathing due to a problem in the chest or to a blocked or runny nose?
Did you seek advice or treatment for the illness from any source?
Where did you seek advice or treatment? Public Sector/Private Medical Sector/NGO Medical Sector/Other source (specify)?

Additional Guidance

DHS8 Model Woman's Questionnaire: questions 618-633
https://dhsprogram.com/pubs/pdf/DHSQ8/DHS8_Womans_QRE_EN_14Feb2023_DHSQ8.pdf

This guidance was prepared by Sheetal Rahi Lookhar ©

Propose Improvements